Otsuka Pharmaceutical Company, Limited

Asahi Kasei Kabushiki Kaisha

Miho Yamamoto

Takeshi Watanabe

Charles Shiner

Keith Friend

Christopher A Zimmer

Marcelo De Freitas Santoro

Amy Freedman

Elaine A O'Hara

Frank S Czerwiec

Craig Ostroff

Kenta Hisamura

A risk management system (RMS) device includes a RMS database and a RMS processor. The RMS processor includes a prescriber module to receive a request to enroll a patient in a RMS program of a therapeutic agent associated with multiple indications. The request includes a specification of at least one indication, and a confirmation of a diagnostic test conducted on the patient. The RMS processor also includes a patient module configured to generate a patient profile. The RMS processor also includes a database module configured to store the patient profile in the RMS database. The RMS processor also includes an authorization module configured to generate an authorization code indicating whether the patient is authorized to receive the therapeutic agent. The RMS processor also includes a communication module configured to transmit the authorization code to a pharmacy or a prescriber.

Device-based risk management of a therapeutic

A conjugated diene-based polymer of the present invention has an absolute molecular weight measured by viscosity detector-equipped GPC-light scattering measurement, of 40&#xd7;10or more and 5000&#xd7;10or less, has a branching number (Bn) measured by the viscosity detector-equipped GPC-light scattering measurement, of 8 or more, and has a modification ratio of 60% by mass or more.

Conjugated diene-based polymer, branching agent, production method for conjugated diene-based polymer, extended conjugated diene-based polymer, rubber composition, and tire

Device based risk management of a therapeutic

Growing community of inventors

Tokyo, Japan

Miho Yamamoto